Table 2.
Means, Standard Deviations, and Rates of Clinically-Significant Cognitive Impairment in Patients and Non-Cancer Comparison Group.
| Patients (n=48) | Comparison subjects (n=48) | Effect size | |||
|---|---|---|---|---|---|
| Mean (SD) | Impaired | Mean (SD) | Impaired | ||
| HLVT Immediate Recall | 43.96 (11.20) | 12 (25%) | 45.69 (9.73) | 7 (15%) | .37 |
| HVLT Delayed Recall | 45.04 (9.87) | 9 (19%) | 46.98 (9.86) | 6 (13%) | .26 |
| BVMT Immediate Recall | 45.15 (12.34) | 12 (25%) | 47.88 (11.71) | 7 (15%) | .37 |
| BVMT Delayed Recall | 49.49 (13.48) | 10 (21%) | 50.94 (11.45) | 5 (10%) | .45 |
| COWA Total | 44.02 (11.15) | 12 (25%) | 45.47 (12.44) | 7 (15%) | .37 |
| Symbol Digit Items Completed | 51.12 (9.35) | 4 (8%) | 50.01 (10.00) | 5 (10%) | −.14 |
| Card Rotations Test | 49.42 (6.99) | 0 (0%) | 48.07 (5.91) | 2 (4%) | -- |
| Overall Impairment | -- | 20 (42%) a | -- | 9 (19%) a | .62 |
| Number of Impaired Tests | 1.23 (1.44) | -- | .81 (1.30) | -- | .31 |
a
Difference between patients and comparison subjects at p<.01
Note: t scores are displayed. Effect sizes refer to differences in rates of impairment.